icon-folder.gif   Conference Reports for NATAP  
  International Workshop on Antiviral
Drug Resistance
June 3-7 2014, Berlin, Germany
Back grey_arrow_rt.gif
Persistence of Resistance-Associated Variants in Hepatitis C Virus (HCV)
Genotype 1-4 Infected Subjects Following 3-day Samatasvir Monotherapy

  Reported by Jules Levin
International Workshop on Antiviral Drug Resistance, June 3-7, 2014 in Berlin, Germany
B Heinrich1, B Vince2, JM Hill3, EJ Lawitz4, W O'Riordan5, LR Webster6, DM Gruener7, RS Mofsen8, A Murillo9, J Chen1, JF McCarville1, K Pietropaolo1, JP Bilello1, L Sweeney1, M Seifer1 and D Mayers1 1 Idenix Pharmaceuticals, Inc., Cambridge, MA, USA; 2 Vince and Associates Clinical Research, Overland Park, KS, USA; 3 Avail Clinical Research, DeLand, FL, USA; 4 Alamo Medical Research, San Antonio, TX, USA; 5 eStudySite, San Diego, CA, USA; 6 CRI Lifetree Clinical Research, Salt Lake City, UT, USA; 7 CRI Worldwide, Philadelphia, PA, USA; 8 St. Louis Clinical Trials, St. Louis, MO, USA; and 9 AMPM Research Clinic, Miami, FL, USA.